SIHUAN PHARM(00460),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

00460 SIHUAN PHARM

Trading 12-23 14:22:38

1.270

+0.000

0.00%

High1.280	Low1.260	Vol12.12M
Open1.280	D1 Closing1.270	Amplitude1.57%
Mkt Cap11.63B	Tradable Cap11.63B	Total Shares9.15B
T/O15.40M	T/O Rate0.13%	Tradable Shares9.15B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"00460","market":"HK","secType":"STK","nameCN":"SIHUAN PHARM","latestPrice":1.27,"timestamp":1766470947539,"preClose":1.27,"halted":0,"volume":12115000,"delay":0,"floatShares":9154000000,"shares":9154000000,"eps":-0.025901496838322796,"marketStatus":"Trading","change":0,"latestTime":"12-23 14:22:38","open":1.28,"high":1.28,"low":1.26,"amount":15402560,"amplitude":0.015748,"askPrice":1.27,"askSize":1641000,"bidPrice":1.26,"bidSize":1316000,"shortable":3,"etf":0,"ttmEps":-0.009733831696105654,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1766477400000},"marketStatusCode":2,"adr":0,"listingDate":1288195200000,"exchange":"SEHK","adjPreClose":1.27,"dividendRate":0.008623,"openAndCloseTimeList":[[1766453400000,1766462400000],[1766466000000,1766476800000]],"volumeRatio":0.76024,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00460","defaultTab":"news","newsList":[{"id":"2592168286","title":"Reframing the Narrative: A Deep Value Re-rating Path for a Transforming Platform— Aesthetics Leader + Innovative Drug Pioneer, an Undervalued Transformation Case","url":"https://stock-news.laohu8.com/highlight/detail?id=2592168286","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592168286?lang=en_us&edition=fundamental","pubTime":"2025-12-19 18:11","pubTimestamp":1766139101,"startTime":"0","endTime":"0","summary":"Initiation of Coverage Report of Sihuan Pharmaceutical Holdings Group Ltd.","market":"us","thumbnail":"https://img7.gelonghui.com/column/2/136.png?guru_height=540&guru_width=375","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/136.png?guru_height=540&guru_width=375"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/3407207","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["00460","BK1191","BK1593","BK1515","BK1600"],"gpt_icon":0},{"id":"2592100903","title":"Sihuan Pharmaceutical's Trustee Buys Back Shares Under Incentive Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=2592100903","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592100903?lang=en_us&edition=fundamental","pubTime":"2025-12-18 20:22","pubTimestamp":1766060537,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical's (HKG:0460) trustee bought back 9 million shares in the firm under a 2022 incentive scheme, a Thursday Hong Kong bourse filing said.The shares, acquired for HK$1.2271 apiece from the market, represent around 0.0983% of the firm's issued shares.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1515","BK1593","BK1600","00460","BK1191"],"gpt_icon":0},{"id":"1142423662","title":"SIHUAN PHARM (00460): Trustee Purchases 9 Million Shares Under Share Award Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=1142423662","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142423662?lang=en_us&edition=fundamental","pubTime":"2025-12-18 19:20","pubTimestamp":1766056814,"startTime":"0","endTime":"0","summary":"SIHUAN PHARM (00460) announced that on December 18, 2025, the trustee purchased a total of 9 million company shares in the market under the share award scheme.","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","BK1191","00460","BK1600","BK1515"],"gpt_icon":0},{"id":"1144929001","title":"Market Focus: Can Real Estate and Consumption Find Momentum?","url":"https://stock-news.laohu8.com/highlight/detail?id=1144929001","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144929001?lang=en_us&edition=fundamental","pubTime":"2025-12-15 09:13","pubTimestamp":1765761187,"startTime":"0","endTime":"0","summary":"**Market Overview**   Last week, neither two key domestic meetings nor the Fed's December rate cut provided significant stimulus to the Hong Kong stock market, primarily due to underwhelming...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1211","MHImain","BK1191","02357","02833","513600","00460","HHImain","BK1167","BK1593","MCHmain","BK1589","HSI","BK1600","01725"],"gpt_icon":0},{"id":"1159093371","title":"SIHUAN PHARM (00460): Innovative Drug Anjiuwei® Successfully Renewed in 2025 National Reimbursement Drug List","url":"https://stock-news.laohu8.com/highlight/detail?id=1159093371","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159093371?lang=en_us&edition=fundamental","pubTime":"2025-12-08 16:48","pubTimestamp":1765183723,"startTime":"0","endTime":"0","summary":"SIHUAN PHARM (00460) announced that, following a simplified renewal negotiation with the National Healthcare Security Administration, its non-wholly owned subsidiary Xuanzhu Biotech's self-developed...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1515","159992","BK1574","BK1600","BK1161","00460","06978","BK1593"],"gpt_icon":0},{"id":"2589385469","title":"Xuanzhu Biopharmaceutical's Anjiuwei Included in 2025 NRDL","url":"https://stock-news.laohu8.com/highlight/detail?id=2589385469","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589385469?lang=en_us&edition=fundamental","pubTime":"2025-12-08 12:09","pubTimestamp":1765166975,"startTime":"0","endTime":"0","summary":"Xuanzhu Biopharmaceutical Co. Ltd. announced the successful renewal and continued inclusion of its innovative drug, Anjiuwei , in the 2025 National Reimbursement Drug List for Basic Medical Insurance, Maternity Insurance, and Work-Related Injury Insurance , effective from January 1, 2026. This follows a medical insurance renewal with the National Healthcare Security Administration . Anjiuwei, the first and only independently developed proton pump inhibitor in China, was approved in June 2023 for the treatment of duodenal ulcers.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xuanzhu Biopharmaceutical Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kon","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nNDL2b7QW2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460","BK1593","BK1600","BK4185","NHC","BK1515","BK1191","02575"],"gpt_icon":0},{"id":"1134728285","title":"10th Zhitong Capital Market Annual Conference Honors Excellence with 25 Awards Unveiled","url":"https://stock-news.laohu8.com/highlight/detail?id=1134728285","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134728285?lang=en_us&edition=fundamental","pubTime":"2025-12-03 19:38","pubTimestamp":1764761917,"startTime":"0","endTime":"0","summary":"On December 3, 2025, the \"10th Zhitong Capital Market Annual Conference & Listed Companies Awards Ceremony,\" jointly hosted by leading Hong Kong and U.S. stock information platform Zhitong Finance...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1555","LU0856984785.SGD","02228","02436","SG9999015952.SGD","LU0605514214.HKD","00855","LU0269904917.USD","LU0828237510.HKD","09926","01681","00363","BK1111","BK1553","LU0348735423.USD","SGXZ86797644.SGD","BK1542","BK1214","LU2106854487.HKD","01093","BK1212","LU1720050803.USD","BK1571","BK1109","IE00BZ08YT58.USD","LU0880133367.SGD","IE00B29SXG58.USD","LU1242518857.USD","01448","BK1531","SG9999003461.SGD","02150","LU0164939612.USD","06609","09992","01440","LU0979878070.USD","LU1023057109.AUD","02380","BK1170","BK1544","BK1583","IE0034224299.USD","LU0348766576.USD","LU0702159699.USD","LU1152091168.USD","BK1554","LU0541502299.USD","BK1520","BK1597","LU1242518931.SGD","LU1102505762.USD","BK1140","BK1161","LU0048597586.USD","LU2097828714.EUR","LU0502904849.HKD","BK1587","LU0823426308.USD","LU0762540952.USD","BK1096","02567","LU0359202008.SGD","LU0823414478.USD","LU2476274308.USD","02382","BK1207","LU1868837722.USD","BK1588","LU0463099449.HKD","BK1142","BK1515","LU0823437842.USD","LU0831093199.SGD","LU1770036033.HKD","LU0320764599.SGD","00512","01735","BK1144","80020","BK1227","LU1808992512.USD","LU0543330566.HKD","03939","09890","LU2424517915.HKD","LU0052756011.USD","03680","06160","LU0823038988.USD","LU0348784397.USD","01117","BK1171","BK1184","LU1166156734.SGD","06100","LU2663582299.SGD","BK1128","02525","LU0449515922.USD","IE00BGHQDM52.EUR","LU0054450605.USD","00305","BK1598","SG9999006597.SGD","LU0370786039.SGD","LU0175139822.USD","LU0865486749.SGD","LU0261950983.USD","06677","03709","00699","00861","02096","LU1880383440.USD","02616","SG9999011746.SGD","LU0348805143.USD","BK1530","LU0128525689.USD","BK1104","BK1137","02177","BK1189","80992","82020","LU2097828805.USD","LU0048575426.USD","IE0031814852.USD","00992","02190","01833","SGXZ62798434.SGD","LU0067412154.USD","LU0173614495.USD","BK1095","LU2328871848.SGD","06862","ANPDY","01530","BK1131","LU2399975544.HKD","LU2177674079.SGD","LU1770034418.SGD","BK1518","06090","BK1167","02696","01318","BK1194","BK1617","01640","09927","BK1592","SGXZ90724238.SGD","LU2460026573.USD","HK0000165453.HKD","LU0289739343.SGD","LU1481107354.HKD","LU2506951792.HKD","01471","BK1521","02451","02142","09961","LU1861214812.USD","02889","LU1048588211.SGD","LU1226287529.USD","02158","02400","02411","BK1578","LU0315179316.USD","LU0251143458.SGD","LU0531970944.HKD","SG9999001903.USD","06168","02506","LU0051755006.USD","LU0588545730.USD","LU0417516902.SGD","BK1548","HYDD.SI","IE00B5MMRT66.SGD","BK1566","09660","01211","LU0588545904.SGD","09878","HK0000320223.HKD","LU1675838814.USD","BK1229","LU1102505929.USD","BK1139","LU1956131251.USD","BK1228","LU1969619763.USD","06913","BK1541","BK1195","SG9999001226.SGD","BK1100","LU1188198961.HKD","LU1981816686.USD","BK1127","BK1147","LU1508157978.USD","LU0314109678.HKD","LU0823397103.USD","LU2294711713.HKD","IE0003795394.USD","LU0611395673.USD","01458","LU1226287792.SGD","01939","LU0072462343.USD","LU2348773727.SGD","LU1226287875.USD","06086","LU0254981946.USD","LU0455707207.USD","BK1158","SG9999000459.SGD","06633","09678","02315","LU2449936058.SGD","IE00B0169L03.USD","LU0737861699.HKD","LU2125910500.SGD","LU1634259391.SGD","LU2153591404.USD","LU0244354667.USD","LU1939255532.USD","02157","BK1136","LU1813983027.USD","LU0307460666.USD","IE0009570106.USD","06657","BK1500","BK1522","03681","06855","LU1807302812.USD","IE00B8HQ1Z84.USD","SG9999004220.SGD","BK1164","01520","LU0011963245.USD","LU1861219969.SGD","LU0516422440.USD","LNNGY","01739","LU1235295612.USD","00666","BK1155","SG9999006514.SGD","LU1831875114.USD","01333","LU0588546209.SGD","BK1577","BK1613","02298","BK1524","LU1366334578.USD","02331","IE00BZ08YR35.GBP","LU0251144936.SGD","BK1190","02552","IE0003851619.USD","SG9999001069.SGD","BK1186","02670","BK1119","BK1526","06069","BK1594","BK1608","BK1619","00826","LU2023250504.SGD","LU0650527681.SGD","LU0541501648.USD","BK1169","BK1183","81211","LU2348774022.SGD","BK1168","LU2357125470.USD","LU1267930227.SGD","06919","02556","IE00BMCWC346.EUR","01762","02020","HK0000320264.USD","LU0082770016.USD","LU0315178854.USD","LU1152091754.HKD","02155","BK1523","03658","01405","02392","LU0043850808.USD","00798","LU0384037296.USD","BK1179","BK1595","00960","LU0823397285.USD","LU1039395188.USD","LU1008478684.HKD","02121","LU0499858438.USD","LU2476274720.SGD","BK1160","LU0054237671.USD","LU0164880469.USD","SG9999014674.SGD","00777","LU1282649810.SGD","09880","02167","BK1589","02498","BK1215","02886","09690","06058","IE00BQXX3F31.USD","LU1951186391.HKD","BK1220","BK1240","BK1237","LU0540923850.HKD","IE0032431581.USD","06608","BK1582","IE00B0JY6N72.USD","LU0348827113.USD","HK0000252160.HKD","LU3063872942.SGD","LU2360107325.USD","HK0000306685.HKD","03650","02250","LU0211977185.USD","LU0588545490.SGD","02420","02595","00384","LU1282649067.USD","LU1868837565.USD","BK1193","LU0259732245.USD","02431","LU0640798160.USD","LU0594300419.USD","01911","SG9999001093.SGD","LU0737861772.HKD","01164","02197","00267","IE00B543WZ88.USD","BK1604","002594","BK1258","00302","BK1134","LU0511384066.AUD","LNVGY","LU0516423091.SGD","LU0516423174.USD","00135","LU1960683339.HKD","09636","LU2249611893.SGD","SG9999000475.SGD","BK1239","LU1634259557.SGD","00884","01877","06996","BK1151","09955","BK1590","BK1175","01600","01818","IE00BVYPNQ40.USD","LU0287142896.SGD","LU2097828631.EUR","BK1117","LU0143863784.USD","LU0819123356.HKD","BYDDY","LU0620787316.HKD","LU2045819591.USD","01773","LU0072913022.USD","LU1974910355.USD","06988","BK1230","09956","LU0140636845.USD","82331","BK1198","LU0326950275.SGD","BK1116","09923","LU0359201612.USD","BK1126","LU0561508036.HKD","LU2543165471.USD","SG9999015986.USD","LU0516422952.EUR","LU0868486357.SGD","LU1719994722.HKD","BK1110","LU0261950470.USD","BK1148","LU0049112450.USD","LU0261947096.USD","BK1247","BK1618","00300","LU1497733631.SGD","LU1328615791.USD","03145","LU0348783233.USD","LU0345775950.USD","01809","02171","BK1606","LU0708995583.HKD","LU1917777945.USD","01384","BK1502","LU0359201885.HKD","01783","09699","IE00BD6J9T35.USD","LU0048580855.USD","BK1143","LU2238339852.HKD","BK1519","02629","02105","LU0572940350.SGD","BK1552","BK1150","LU1794554557.SGD","LU0231483743.USD","02858","BK1557","LU0456827905.SGD","BK1609","BK1560","01177","LU2778985437.USD","BK1574","LU0052750758.USD","01119","00017","BK1216","BK1575","LU0572939691.SGD","LU0327786744.USD","03800","BK1224","LU0143863198.USD","LU0531971595.HKD","IE00B031HY20.USD","86618","LU0871576103.HKD","00136","02565","BK1586","02268","LU0791591158.USD","LU0634319403.HKD","01519","LU2506952253.HKD","BK1219","LU0228659784.USD","LU0164865239.USD","LU0348825331.USD","01952","02273","BK1539","09860","LU1226288170.HKD","LU0264606111.USD","LU0449509016.USD","09985","IE0008368742.USD","LU1226288253.USD","02650","02509","LU1251922891.USD","02013","03998","BK1114","LU2298064838.USD","BK1600","BK1605","BK1257","LU1303224171.USD","02511","BK1504","BK1564","01585","LU2008162690.USD","02551","00460","09996","02100","LU0274383008.USD","BK1616","LU1224709979.USD","LU0456846285.SGD","BK1550","LU1211504680.USD","BK1559","SG9999004311.SGD","LU0289961442.SGD","BK1197","01880","LU0229945570.USD","BK1125","00003","BK1233","LU1961090484.USD","SG9999002828.SGD","06613","LU0329678337.USD","02145","BK1591","IE00BPRC5H50.USD","06138","BK1154","LU0165289439.USD","BK1593","02057","LU0164872284.USD","IE00BVYPNP33.GBP","LU2153592121.USD","LU0488056044.USD","LU1880383366.USD","02419","BK1163","00656","BK1528","03677","BK1615","06060","09990","LU1046422090.SGD","BK1607","IE0008369823.USD","02018","06683","02279","06186","BK1132","IE00BZ08YS42.EUR","LU0469268626.HKD","LU0509642566.USD","02627","LU0149721374.USD","LU1868838027.USD","LU0828238088.HKD","09919","LU2097828557.USD","IE00BQXX3C00.GBP","01070","BK1512","LU0499858602.USD","BK1579","00867","BK1209","LU0572944931.SGD","03896","01276","LU0593848301.USD","BK1191","02598","01907","BK1235","02469","00875","IE00B031J352.USD","00382","09877","BK1188","BK1178","SG9999002463.SGD","LU0084288322.USD","02256","BK1124","IE00BYV24P56.USD","LU0505663152.USD","09959","03396","02488","BK1222","BK1200","BK1540","IE00BQXX3D17.EUR","LU0214875030.USD","BK1221","BK1527","BK1509","01651","LU2488822045.USD","LU0823039010.USD","SG9999001051.SGD","02460","HK0000252152.HKD","BK1516","LU0289960550.SGD","BK1596","LU0329678170.USD","LU0417516571.SGD","SG9999002562.SGD","LU0823414551.USD","LU2242644610.SGD","SG9999015945.SGD","HK0000306701.USD","03738","IE00B8L5B284.USD","02587","LU0348767384.USD","02590","LU1497734951.SGD","BK1556","02453","HK0000500386.USD","LU0431992006.USD","LU0310800965.SGD","BK1585","LU2097828474.EUR","BK1549","00451","LU0501845795.SGD","LU0345776255.USD","LU1993786604.SGD","SG9999015978.USD","LU0791590937.USD","09911","LU1328277881.USD","LU1366334651.USD","IE00BGV7N243.SGD","LU0082770016.SGD","LU0417516738.SGD","LU1115378108.SGD","09639","LU0107464264.USD","LU0819121731.USD","LU0516422366.SGD","02276","BK1141","00020","LU0594300179.USD","BK1610","SG9999000418.SGD","06821","BK1253","LU1497733557.USD","LU0039217434.USD","LU0823426480.USD","LU1522347837.USD","SG9999002950.SGD","00999","06963","06618","01969","01378","LU2039709279.SGD","02533","03836","BK1225"],"gpt_icon":1},{"id":"1162985725","title":"Sihuan Pharmaceutical (00460) Announces November 2025 Equity Movements, No Changes to Share Structure","url":"https://stock-news.laohu8.com/highlight/detail?id=1162985725","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162985725?lang=en_us&edition=fundamental","pubTime":"2025-12-01 16:21","pubTimestamp":1764577301,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical Holdings Group Ltd. (00460) released its monthly return, covering equity issuer movements for November 2025. The authorized share capital remained at 100,000,000,000 ordinary...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460"],"gpt_icon":0},{"id":"2584937069","title":"Investors push Sihuan Pharmaceutical Holdings Group (HKG:460) 4.2% lower this week, company's increasing losses might be to blame","url":"https://stock-news.laohu8.com/highlight/detail?id=2584937069","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584937069?lang=en_us&edition=fundamental","pubTime":"2025-11-19 07:10","pubTimestamp":1763507408,"startTime":"0","endTime":"0","summary":"Passive investing in index funds can generate returns that roughly match the overall market. But if you pick the right...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-460/sihuan-pharmaceutical-holdings-group-shares/news/investors-push-sihuan-pharmaceutical-holdings-group-hkg460-4","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-460/sihuan-pharmaceutical-holdings-group-shares/news/investors-push-sihuan-pharmaceutical-holdings-group-hkg460-4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1191","ISBC","BK1515","BK1600","BK1593","BK4211","00460"],"gpt_icon":0},{"id":"1169932779","title":"Sihuan Pharmaceutical (0460) Announces Proposed H Share Full Circulation for Xuanzhu Biopharma (2575)","url":"https://stock-news.laohu8.com/highlight/detail?id=1169932779","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169932779?lang=en_us&edition=fundamental","pubTime":"2025-11-18 23:21","pubTimestamp":1763479293,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical (0460) announced that its subsidiary, Xuanzhu Biopharma (2575), is proceeding with a proposal for H share full circulation. According to announcements dated 14 November 2025 and...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460"],"gpt_icon":0},{"id":"2584802956","title":"Xuanzhu Biopharma Moves to Convert Shares for H Share Full Circulation","url":"https://stock-news.laohu8.com/highlight/detail?id=2584802956","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584802956?lang=en_us&edition=fundamental","pubTime":"2025-11-18 22:54","pubTimestamp":1763477676,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical Holdings Group Ltd. announced that its subsidiary, Xuanzhu Biopharmaceutical Co., Ltd., has filed an application with the China Securities Regulatory Commission for the conversion of 357,245,794 unlisted shares into H shares on a one-on-one basis, representing approximately 68.97% of Xuanzhu Biopharma's total issued shares as of 14 November 2025. Xuanzhu Biopharma is listed on the Main Board of the Hong Kong Stock Exchange under stock code 2575.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sihuan Pharmaceutical Holdings Group Ltd. published the original content used to generate this news brief on November 18, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nNDL39d64y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","00460","BK1600","BK1593","BK1515"],"gpt_icon":0},{"id":"1158632927","title":"SIHUAN PHARM Surges Over 4% in Early Trading After Signing Collaboration Agreement with U.S.'s AbaloneBio","url":"https://stock-news.laohu8.com/highlight/detail?id=1158632927","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158632927?lang=en_us&edition=fundamental","pubTime":"2025-10-30 11:20","pubTimestamp":1761794439,"startTime":"0","endTime":"0","summary":"SIHUAN PHARM (00460) rose more than 4% in early trading, with shares up 4.11% to HKD 1.52 at the time of writing, recording a turnover of HKD 57.79 million. On October 30, SIHUAN PHARM announced that...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460","BK1191","BK1593","BK1515","BK1600"],"gpt_icon":0},{"id":"2579152824","title":"BRIEF-Sihuan Pharma Signs Agreement With Abalone Bio","url":"https://stock-news.laohu8.com/highlight/detail?id=2579152824","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579152824?lang=en_us&edition=fundamental","pubTime":"2025-10-30 09:20","pubTimestamp":1761787251,"startTime":"0","endTime":"0","summary":"BRIEF-Sihuan Pharma Signs Agreement With Abalone BioOct 30 (Reuters) - Sihuan Pharmaceutical Holdings Group Ltd 0460.HK:SIGNS AGREEMENT WITH ABALONE BIOCO AND ABALONE TO DEVELOP NEW OBESITY DRUGFurther company coverage: 0460.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nFWN3WA2HF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460","BK1600","BK1191","BK1593","BK1515"],"gpt_icon":0},{"id":"1124178700","title":"SIHUAN PHARM (00460) Signs Collaboration Agreement with U.S.'s AbaloneBio to Jointly Develop Next-Generation Weight Loss and Muscle-Building Therapy, Further Expanding GPCR Target Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=1124178700","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124178700?lang=en_us&edition=fundamental","pubTime":"2025-10-30 08:14","pubTimestamp":1761783261,"startTime":"0","endTime":"0","summary":"SIHUAN PHARM (00460) announced that the group has formally entered into a collaboration agreement with U.S. biotech firm AbaloneBio (Abalone). Under the agreement, the two parties will collaborate...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK4007","00460","BK1600","BK4599","GPCR","BK1593","BK1515"],"gpt_icon":0},{"id":"1137951256","title":"Sihuan Pharmaceutical (0460) and Abalone Bio Sign Cooperation for Next-Generation Obesity Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=1137951256","media":"Bulletin Express","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137951256?lang=en_us&edition=fundamental","pubTime":"2025-10-30 08:11","pubTimestamp":1761783067,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical Holdings Group Ltd. (0460) has signed a cooperation agreement with U.S.-based biotechnology company Abalone Bio to carry out global research and development of a new-generation...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460"],"gpt_icon":0},{"id":"2579156349","title":"Sihuan Pharmaceutical Partners with Abalone Bio to Develop Innovative Weight Loss Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2579156349","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579156349?lang=en_us&edition=fundamental","pubTime":"2025-10-30 08:01","pubTimestamp":1761782509,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical Holdings Group Ltd. has announced the signing of a cooperation agreement with U.S.-based biotechnology company Abalone Bio. Under this agreement, the two companies will collaborate globally to jointly develop a new-generation innovative therapy aimed at weight loss and muscle gain, further strengthening Sihuan Pharmaceutical's presence in the GPCR  target field. The partnership reflects the company's ongoing commitment to innovation in the medical aesthetics and biopharmaceutical sectors.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sihuan Pharmaceutical Holdings Group Ltd. published the original content used to generate this news brief on October 30, 2025, and is solely responsible for the information contained","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nNDL4SrjYz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460","BK1600","BK1191","BK1593","BK1515"],"gpt_icon":0},{"id":"2579315637","title":"Sihuan Pharma - Co and Abalone to Develop New Obesity Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2579315637","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579315637?lang=en_us&edition=fundamental","pubTime":"2025-10-30 08:00","pubTimestamp":1761782459,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nFWN3WA2HF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1600","BK1191","00460","BK1593","BK1515"],"gpt_icon":0},{"id":"1129756753","title":"NG-350A Receives U.S. FDA Fast Track: Sihuan Pharmaceutical (0460) and Xuanzhu Biopharm Progress in Rectal Cancer Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=1129756753","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129756753?lang=en_us&edition=fundamental","pubTime":"2025-10-28 17:34","pubTimestamp":1761644071,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical Holdings Group Ltd. (Stock Code: 0460) announced that NG‑350A, developed by its non wholly-owned subsidiary Xuanzhu Biopharmaceutical Co., Ltd. (Xuanzhu Biopharm) under a...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460"],"gpt_icon":0},{"id":"2578938002","title":"Sihuan Pharmaceutical Wins FDA Fast Track for NG-350A in Rectal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2578938002","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578938002?lang=en_us&edition=fundamental","pubTime":"2025-10-28 16:42","pubTimestamp":1761640959,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical Holdings Group Ltd. announced that NG-350A, a product developed by its non-wholly owned subsidiary Xuanzhu Biopharmaceutical Co., Ltd. and licensed from Akamis Bio Ltd., has been granted Fast Track designation by the U.S. Food and Drug Administration . The designation is for the treatment of mismatch repair-proficient  locally advanced rectal cancer . Xuanzhu Biopharm holds exclusive rights to develop, produce, and commercialize NG-350A in Greater China.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sihuan Pharmaceutical Holdings Group Ltd. published the original content used to generate this news brief on October 28, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251028:nNDL9hL4Bt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460","BK1191","BK1593","BK1515","BK1600"],"gpt_icon":0},{"id":"2578938159","title":"Sihuan Pharma - Ng-350a Granted Fast Track Designation by U.S. FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2578938159","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578938159?lang=en_us&edition=fundamental","pubTime":"2025-10-28 16:36","pubTimestamp":1761640603,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251028:nFWN3W90CD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1593","00460","BK1515","BK1600","BK1191"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sihuanpharm.com.cn","stockEarnings":[{"period":"1week","weight":-0.0078},{"period":"1month","weight":-0.0231},{"period":"3month","weight":-0.2058},{"period":"6month","weight":0.1024},{"period":"1year","weight":0.9389},{"period":"ytd","weight":0.9389}],"compareEarnings":[{"period":"1week","weight":0.0067},{"period":"1month","weight":0.0231},{"period":"3month","weight":-0.0137},{"period":"6month","weight":0.0542},{"period":"1year","weight":0.3084},{"period":"ytd","weight":0.2862}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Sihuan Pharmaceutical Holdings Group Ltd is an investment holding company primarily engaged in the research and development, manufacture and sale of pharmaceutical products and aesthetic products. The Company operates its business through three segments. The Medical Aesthetic Products segment includes the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care and others to provide non- or minimally invasive medical aesthetic comprehensive solutions. The Innovative Medicine and Other Medicine segment is engaged in the research and development and commercialization of innovative medicine in the disease fields of diabetes, breast cancer, digestion disorders, oncology and non-alcoholic steatohepatitis and others. The Generic Medicine segment is engaged in the production and sale of generic medicine including Kelin’ao and other products. The Company conducts its business in the domestic and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.108058},{"month":2,"riseRate":0.533333,"avgChangeRate":0.001687},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.025898},{"month":4,"riseRate":0.571429,"avgChangeRate":0.046025},{"month":5,"riseRate":0.428571,"avgChangeRate":0.020898},{"month":6,"riseRate":0.571429,"avgChangeRate":0.003131},{"month":7,"riseRate":0.571429,"avgChangeRate":0.007501},{"month":8,"riseRate":0.5,"avgChangeRate":-0.014353},{"month":9,"riseRate":0.214286,"avgChangeRate":-0.045133},{"month":10,"riseRate":0.571429,"avgChangeRate":0.029461},{"month":11,"riseRate":0.466667,"avgChangeRate":0.008386},{"month":12,"riseRate":0.4,"avgChangeRate":-0.015612}],"exchange":"SEHK","name":"SIHUAN PHARM","nameEN":"SIHUAN PHARM"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SIHUAN PHARM(00460),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest SIHUAN PHARM(00460) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"SIHUAN PHARM,00460,SIHUAN PHARM股票,SIHUAN PHARM股票老虎,SIHUAN PHARM股票老虎国际,SIHUAN PHARM行情,SIHUAN PHARM股票行情,SIHUAN PHARM股价,SIHUAN PHARM股市,SIHUAN PHARM股票价格,SIHUAN PHARM股票交易,SIHUAN PHARM股票购买,SIHUAN PHARM股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SIHUAN PHARM(00460),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest SIHUAN PHARM(00460) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}